|
1
|
Ben-Porath I and Weinberg RA: The signals
and pathways activating cellular senescence. Int J Biochem Cell
Biol. 37:961–976. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu S, Liu S, Wang X, Zhou J, Cao Y, Wang
F and Duan E: The PI3K-Akt pathway inhibits senescence and promotes
self-renewal of human skin-derived precursors in vitro. Aging Cell.
10:661–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Salama R, Sadaie M, Hoare M and Narita M:
Cellular senescence and its effector programs. Genes Dev.
28:99–114. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Campisi J and d'Adda di Fagagna F:
Cellular senescence: When bad things happen to good cells. Nat Rev
Mol Cell Biol. 8:729–740. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Deng Y, Chan SS and Chang S: Telomere
dysfunction and tumour suppression: The senescence connection. Nat
Rev Cancer. 8:450–458. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Michaloglou C, Vredeveld LC, Soengas MS,
Denoyelle C, Kuilman T, van der Horst CM, Majoor DM, Shay JW, Mooi
WJ and Peeper DS: BRAFE600-associated senescence-like cell cycle
arrest of human naevi. Nature. 436:720–724. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Braig M, Lee S, Loddenkemper C, Rudolph C,
Peters AH, Schlegelberger B, Stein H, Dörken B, Jenuwein T and
Schmitt CA: Oncogene-induced senescence as an initial barrier in
lymphoma development. Nature. 436:660–665. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun P, Yoshizuka N, New L, Moser BA, Li Y,
Liao R, Xie C, Chen J, Deng Q, Yamout M, et al: PRAK is essential
for ras-induced senescence and tumor suppression. Cell.
128:295–308. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Naylor RM, Baker DJ and van Deursen JM:
Senescent cells: A novel therapeutic target for aging and
age-related diseases. Clin Pharmacol Ther. 93:105–116. 2013.
View Article : Google Scholar
|
|
10
|
Coppé JP, Desprez PY, Krtolica A and
Campisi J: The senescence-associated secretory phenotype: The dark
side of tumor suppression. Annu Rev Pathol. 5:99–118. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Campisi J: Cellular senescence: Putting
the paradoxes in perspective. Curr Opin Genet Dev. 21:107–112.
2011. View Article : Google Scholar :
|
|
12
|
Kang TW, Yevsa T, Woller N, Hoenicke L,
Wuestefeld T, Dauch D, Hohmeyer A, Gereke M, Rudalska R, Potapova
A, et al: Senescence surveillance of pre-malignant hepatocytes
limits liver cancer development. Nature. 479:547–551. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xue W, Zender L, Miething C, Dickins RA,
Hernando E, Krizhanovsky V, Cordon-Cardo C and Lowe SW: Senescence
and tumour clearance is triggered by p53 restoration in murine
liver carcinomas. Nature. 445:656–660. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Byun HO, Han NK, Lee HJ, Kim KB, Ko YG,
Yoon G, Lee YS, Hong SI and Lee JS: Cathepsin D and eukaryotic
translation elongation factor 1 as promising markers of cellular
senescence. Cancer Res. 69:4638–4647. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jung SH, Lee HC, Yu DM, Kim BC, Park SM,
Lee YS, Park HJ, Ko YG and Lee JS: Heparan sulfation is essential
for the prevention of cellular senescence. Cell Death Differ. Aug
7–2015.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim BC, Yoo HJ, Lee HC, Kang KA, Jung SH,
Lee HJ, Lee M, Park S, Ji YH, Lee YS, et al: Evaluation of
premature senescence and senescence biomarkers in carcinoma cells
and xenograft mice exposed to single or fractionated irradiation.
Oncol Rep. 31:2229–2235. 2014.PubMed/NCBI
|
|
17
|
Weichhaus M, Segaran P, Renaud A, Geerts D
and Connelly L: Osteoprotegerin expression in triple-negative
breast cancer cells promotes metastasis. Cancer Med. 3:1112–1125.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vakkila J and Lotze MT: Inflammation and
necrosis promote tumour growth. Nat Rev Immunol. 4:641–648. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Joyce JA: Therapeutic targeting of the
tumor microenvironment. Cancer Cell. 7:513–520. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zender L and Rudolph KL: Keeping your
senescent cells under control. Aging (Albany NY). 1:438–441.
2009.
|
|
22
|
Schmitt CA: Cellular senescence and cancer
treatment. Biochim Biophys Acta. 1775:5–20. 2007.
|
|
23
|
de Visser KE, Eichten A and Coussens LM:
Paradoxical roles of the immune system during cancer development.
Nat Rev Cancer. 6:24–37. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gewirtz DA, Holt SE and Elmore LW:
Accelerated senescence: An emerging role in tumor cell response to
chemotherapy and radiation. Biochem Pharmacol. 76:947–957. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ramkumar C, Kong Y, Trabucco SE, Gerstein
RM and Zhang H: Smurf2 regulates hematopoietic stem cell
self-renewal and aging. Aging Cell. 13:478–486. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nardella C, Clohessy JG, Alimonti A and
Pandolfi PP: Pro-senescence therapy for cancer treatment. Nat Rev
Cancer. 11:503–511. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Velarde MC, Demaria M and Campisi J:
Senescent cells and their secretory phenotype as targets for cancer
therapy. Interdiscip Top Gerontol. 38:17–27. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rodier F, Coppé JP, Patil CK, Hoeijmakers
WA, Muñoz DP, Raza SR, Freund A, Campeau E, Davalos AR and Campisi
J: Persistent DNA damage signalling triggers senescence-associated
inflammatory cytokine secretion. Nat Cell Biol. 11:973–979. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ren JL, Pan JS, Lu YP, Sun P and Han J:
Inflammatory signaling and cellular senescence. Cell Signal.
21:378–383. 2009. View Article : Google Scholar
|
|
30
|
Novakova Z, Hubackova S, Kosar M,
Janderova-Rossmeislova L, Dobrovolna J, Vasicova P, Vancurova M,
Horejsi Z, Hozak P, Bartek J, et al: Cytokine expression and
signaling in drug-induced cellular senescence. Oncogene.
29:273–284. 2010. View Article : Google Scholar
|
|
31
|
Orjalo AV, Bhaumik D, Gengler BK, Scott GK
and Campisi J: Cell surface-bound IL-1alpha is an upstream
regulator of the senescence-associated IL-6/IL-8 cytokine network.
Proc Natl Acad Sci USA. 106:17031–17036. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cichowski K and Hahn WC: Unexpected pieces
to the senescence puzzle. Cell. 133:958–961. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jiang H, Schiffer E, Song Z, Wang J,
Zürbig P, Thedieck K, Moes S, Bantel H, Saal N, Jantos J, et al:
Proteins induced by telomere dysfunction and DNA damage represent
biomarkers of human aging and disease. Proc Natl Acad Sci USA.
105:11299–11304. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz
DP, Goldstein J, Nelson PS, Desprez PY and Campisi J:
Senescence-associated secretory phenotypes reveal
cell-nonautonomous functions of oncogenic RAS and the p53 tumor
suppressor. PLoS Biol. 6:2853–2868. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nickoloff BJ, Lingen MW, Chang BD, Shen M,
Swift M, Curry J, Bacon P, Bodner B and Roninson IB: Tumor
suppressor maspin is up-regulated during keratinocyte senescence,
exerting a paracrine antiangiogenic activity. Cancer Res.
64:2956–2961. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vávrová J and Rezáčová M: The importance
of senescence in ionizing radiation-induced tumour suppression.
Folia Biol (Praha). 57:41–46. 2011.
|
|
37
|
Sabin RJ and Anderson RM: Cellular
Senescence - its role in cancer and the response to ionizing
radiation. Genome Integr. 2:72011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Han NK, Kim BC, Lee HC, Lee YJ, Park MJ,
Chi SG, Ko YG and Lee JS: Secretome analysis of ionizing
radiation-induced senescent cancer cells reveals that secreted RKIP
plays a critical role in neighboring cell migration. Proteomics.
12:2822–2832. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Baud'huin M, Duplomb L, Teletchea S,
Lamoureux F, Ruiz-Velasco C, Maillasson M, Redini F, Heymann MF and
Heymann D: Osteoprotegerin: Multiple partners for multiple
functions. Cytokine Growth Factor Rev. 24:401–409. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Walsh MC and Choi Y: Biology of the
RANKL-RANK-OPG system in immunity, bone, and beyond. Front Immunol.
5:5112014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dougall WC: Molecular pathways:
Osteoclast-dependent and osteoclast-independent roles of the
RANKL/RANK/OPG pathway in tumorigenesis and metastasis. Clin Cancer
Res. 18:326–335. 2012. View Article : Google Scholar
|
|
42
|
Reid PE, Brown NJ and Holen I: Breast
cancer cells stimulate osteoprotegerin (OPG) production by
endothelial cells through direct cell contact. Mol Cancer.
8:492009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lamoureux F, Moriceau G, Picarda G,
Rousseau J, Trichet V and Rédini F: Regulation of osteoprotegerin
pro- or anti-tumoral activity by bone tumor microenvironment.
Biochim Biophys Acta. 1805:17–24. 2010.
|
|
44
|
Kishida S, Mu P, Miyakawa S, Fujiwara M,
Abe T, Sakamoto K, Onishi A, Nakamura Y and Kadomatsu K: Midkine
promotes neuroblastoma through Notch2 signaling. Cancer Res.
73:1318–1327. 2013. View Article : Google Scholar
|
|
45
|
Kishida S and Kadomatsu K: Involvement of
midkine in neuroblastoma tumourigenesis. Br J Pharmacol.
171:896–904. 2014. View Article : Google Scholar :
|
|
46
|
Yao J, Li WY, Li SG, Feng XS and Gao SG:
Midkine promotes perineural invasion in human pancreatic cancer.
World J Gastroenterol. 20:3018–3024. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hao H, Maeda Y, Fukazawa T, Yamatsuji T,
Takaoka M, Bao XH, Matsuoka J, Okui T, Shimo T, Takigawa N, et al:
Inhibition of the growth factor MDK/midkine by a novel small
molecule compound to treat non-small cell lung cancer. PLoS One.
8:e710932013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen YC, Pohl G, Wang TL, Morin PJ,
Risberg B, Kristensen GB, Yu A, Davidson B and Shih IeM:
Apolipoprotein E is required for cell proliferation and survival in
ovarian cancer. Cancer Res. 65:331–337. 2005.PubMed/NCBI
|
|
49
|
Li Y, Cam J and Bu G: Low-density
lipoprotein receptor family: Endocytosis and signal transduction.
Mol Neurobiol. 23:53–67. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lynch JR, Morgan D, Mance J, Matthew WD
and Laskowitz DT: Apolipoprotein E modulates glial activation and
the endogenous central nervous system inflammatory response. J
Neuroimmunol. 114:107–113. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Su WP, Chen YT, Lai WW, Lin CC, Yan JJ and
Su WC: Apolipoprotein E expression promotes lung adenocarcinoma
proliferation and migration and as a potential survival marker in
lung cancer. Lung Cancer. 71:28–33. 2011. View Article : Google Scholar
|
|
52
|
Wolf AB, Valla J, Bu G, Kim J, LaDu MJ,
Reiman EM and Caselli RJ: Apolipoprotein E as a
β-amyloid-independent factor in Alzheimer's disease. Alzheimers Res
Ther. 5:382013. View Article : Google Scholar
|
